Drugs for high cholesterol and migraine could become OTC in the U.S. But without a comprehensive behind-the-counter ...
Polyrizon Ltd. (Nasdaq: PLRZ) ('Polyrizon” or the 'Company”), a biotechnology company focusing on the development of ...
Ecstasy or molly is often linked to festival and rave culture. But the so-called party drug carries far more risks today than ...
It’s hard to remember that there was a Republican presidential nominating contest last year, but it really did happen. The reason it is so easy to forget is that the front-runner and inevitable ...
In addition to CG001419, Cullgen continues the advancement of CG009301, a GSPT1 degrader being studied in a Phase 1 trial for the treatment of blood cancers, as well as progressing its pipeline of pre ...
These numbers would make some sense if the drug in question were the deadly synthetic opioid fentanyl: The Drug Enforcement ...
Weiser was fired from the CDC during mass layoffs in April, was rehired in June, and then resigned. He continues to treat ...
Emergent BioSolutions (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental Biologics License ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated commercial-stage biotechnology company today announced the appointment of Irina Ishak as General ...
Good day, and welcome to the IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025. The next presenting company is Scienture Holdings, Inc. [Operator Instructions] I would now like to ...
HIV physician John Weiser talks about why complying with President Donald Trump’s orders to erase transgender people is bad for science and society. And he notes that acquiescing didn’t spare the CDC ...